Vertex Pharmaceuticals, Inc. (VRTX)
447.26
+0.72
(+0.16%)
USD |
NASDAQ |
Apr 01, 16:00
446.88
-0.38
(-0.08%)
Pre-Market: 20:00
Vertex Pharmaceuticals Research and Development Expense (TTM) : 3.929B for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 5.688B |
| Moderna, Inc. | 2.917B |
| Amgen, Inc. | 7.281B |
| Eli Lilly & Co. | 13.34B |
| Pfizer Inc. | 10.25B |